Serafí Cambray

881 total citations
24 papers, 560 citations indexed

About

Serafí Cambray is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Nephrology. According to data from OpenAlex, Serafí Cambray has authored 24 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 7 papers in Molecular Biology and 5 papers in Nephrology. Recurrent topics in Serafí Cambray's work include Parathyroid Disorders and Treatments (5 papers), Cardiovascular Health and Disease Prevention (4 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Serafí Cambray is often cited by papers focused on Parathyroid Disorders and Treatments (5 papers), Cardiovascular Health and Disease Prevention (4 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Serafí Cambray collaborates with scholars based in Spain, United Kingdom and United States. Serafí Cambray's co-authors include Francisco Purroy, Ikram Benabdelhak, Charles Arber, Mark A. Ungless, Tristan A. Rodríguez, Jordi Sanahuja, Marcelino Bermúdez-López, José Manuel Valdivielso, Reinald Pamplona and Gerard Mauri and has published in prestigious journals such as Nature Communications, Molecular and Cellular Biology and Development.

In The Last Decade

Serafí Cambray

24 papers receiving 557 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Serafí Cambray Spain 12 314 158 108 76 53 24 560
Qichao Wu China 17 228 0.7× 82 0.5× 66 0.6× 50 0.7× 31 0.6× 44 658
Patricia L. Musolino United States 17 367 1.2× 97 0.6× 84 0.8× 27 0.4× 42 0.8× 39 678
Chengcheng Cui China 13 495 1.6× 86 0.5× 87 0.8× 29 0.4× 40 0.8× 21 870
Jun Zhong China 16 294 0.9× 58 0.4× 124 1.1× 60 0.8× 112 2.1× 43 724
Andrew Rolfe United States 11 384 1.2× 90 0.6× 94 0.9× 149 2.0× 18 0.3× 13 675
Mengna Peng China 9 256 0.8× 47 0.3× 53 0.5× 38 0.5× 42 0.8× 16 511
Shengnian Zhou China 14 208 0.7× 93 0.6× 52 0.5× 53 0.7× 35 0.7× 30 494
Donghe Han China 15 274 0.9× 86 0.5× 145 1.3× 20 0.3× 19 0.4× 18 676
Yue Xia China 15 224 0.7× 93 0.6× 59 0.5× 12 0.2× 47 0.9× 36 554
Adriana Redensek Canada 9 279 0.9× 180 1.1× 27 0.3× 34 0.4× 38 0.7× 9 627

Countries citing papers authored by Serafí Cambray

Since Specialization
Citations

This map shows the geographic impact of Serafí Cambray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serafí Cambray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serafí Cambray more than expected).

Fields of papers citing papers by Serafí Cambray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serafí Cambray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serafí Cambray. The network helps show where Serafí Cambray may publish in the future.

Co-authorship network of co-authors of Serafí Cambray

This figure shows the co-authorship network connecting the top 25 collaborators of Serafí Cambray. A scholar is included among the top collaborators of Serafí Cambray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serafí Cambray. Serafí Cambray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bermúdez-López, Marcelino, Jessica González, Reinald Pamplona, et al.. (2023). Cumulative tobacco consumption has a dose-dependent effect on atheromatosis burden and improves severe atheromatosis prediction in asymptomatic middle-aged individuals: The ILERVAS study. Atherosclerosis. 375. 75–83. 5 indexed citations
2.
Bermúdez-López, Marcelino, Àngels Betriu, Serafí Cambray, et al.. (2020). Subclinical atheromatosis localization and burden in a low-to-moderate cardiovascular risk population: the ILERVAS study. Revista Española de Cardiología (English Edition). 74(12). 1042–1053. 11 indexed citations
3.
Cambray, Serafí, Mercè Ibarz, Marcelino Bermúdez-López, et al.. (2020). Magnesium Levels Modify the Effect of Lipid Parameters on Carotid Intima Media Thickness. Nutrients. 12(9). 2631–2631. 13 indexed citations
4.
Cambray, Serafí, et al.. (2020). CYP24A1 and KL polymorphisms are associated with the extent of vascular calcification but do not improve prediction of cardiovascular events. Nephrology Dialysis Transplantation. 36(11). 2076–2083. 2 indexed citations
5.
6.
Bermúdez-López, Marcelino, et al.. (2020). P0878INDEPENDENT EFFECTS OF SECONDARY HYPERPARATHYROIDISM ON CHRONIC KIDNEY DISEASE PROGRESSION AND CARDIOVASCULAR EVENTS IN THE NEFRONA COHORT. Nephrology Dialysis Transplantation. 35(Supplement_3). 1 indexed citations
7.
Valls, Joan, Serafí Cambray, Milica Božić, et al.. (2019). Association of Candidate Gene Polymorphisms With Chronic Kidney Disease: Results of a Case-Control Analysis in the Nefrona Cohort. Frontiers in Genetics. 10. 118–118. 11 indexed citations
8.
Bermúdez-López, Marcelino, Carles Forné, Núria Amigó, et al.. (2019). An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients. Expert Opinion on Therapeutic Targets. 23(7). 619–630. 38 indexed citations
9.
10.
Borràs, Mercè, Serafí Cambray, Maria Crespo‐Masip, et al.. (2018). Peritoneal Dialysis Is an Independent Factor Associated to Lower Intima Media Thickness in Dialysis Patients Free From Previous Cardiovascular Disease. Frontiers in Physiology. 9. 1743–1743. 4 indexed citations
11.
Cambray, Serafí, Manuel Portero-Otı́n, Mariona Jové, et al.. (2017). Metabolomic Estimation of the Diagnosis and Onset Time of Permanent and Transient Cerebral Ischemia. Molecular Neurobiology. 55(7). 6193–6200. 8 indexed citations
12.
Royo, José Luís, et al.. (2017). The rs2108622 polymorphism is related to the early risk of ischemic stroke in non-valvular atrial fibrillation subjects under oral anticoagulation. The Pharmacogenomics Journal. 18(5). 652–656. 2 indexed citations
13.
14.
Purroy, Francisco, Serafí Cambray, Gerard Mauri, et al.. (2016). Metabolomics Predicts Neuroimaging Characteristics of Transient Ischemic Attack Patients. EBioMedicine. 14. 131–138. 19 indexed citations
15.
Purroy, Francisco, Serafí Cambray, Ikram Benabdelhak, et al.. (2015). The determination of copeptin levels helps management decisions among transient ischaemic attack patients. Acta Neurologica Scandinavica. 134(2). 140–147. 13 indexed citations
16.
Arber, Charles, Sophie V. Precious, Serafí Cambray, et al.. (2015). Activin A directs striatal projection neuron differentiation of human pluripotent stem cells. Development. 142(7). 1375–1386. 117 indexed citations
17.
Leyva‐Díaz, Eduardo, Daniel del Toro, Serafí Cambray, et al.. (2014). FLRT3 Is a Robo1-Interacting Protein that Determines Netrin-1 Attraction in Developing Axons. Current Biology. 24(5). 494–508. 66 indexed citations
18.
Jové, Mariona, Gerard Mauri, Serafí Cambray, et al.. (2014). Metabolomics predicts stroke recurrence after transient ischemic attack. Neurology. 84(1). 36–45. 81 indexed citations
19.
Cambray, Serafí, Charles Arber, Graham Little, et al.. (2012). Activin induces cortical interneuron identity and differentiation in embryonic stem cell-derived telencephalic neural precursors. Nature Communications. 3(1). 841–841. 57 indexed citations
20.
Mignon, M, D Rigaud, Serafí Cambray, et al.. (1985). A Comparative Evaluation of Secretin Bolus and Secretin Infusion as Secretin Provocation Tests in the Zollinger-Ellison Syndrome. Scandinavian Journal of Gastroenterology. 20(7). 791–797. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qichao Wu Breakdown of academic impact, for papers by Patricia L. Musolino Breakdown of academic impact, for papers by Chengcheng Cui Breakdown of academic impact, for papers by Jun Zhong Breakdown of academic impact, for papers by Andrew Rolfe Breakdown of academic impact, for papers by Mengna Peng Breakdown of academic impact, for papers by Shengnian Zhou Breakdown of academic impact, for papers by Donghe Han Breakdown of academic impact, for papers by Yue Xia Breakdown of academic impact, for papers by Adriana Redensek
Rankless by CCL
2026